Neomycin sulfate ≥600 µg/mg USP

Supplier: Test
Ratings: (No Reviews)

Total Ratings: 0
Avg. Ratings: 0.0 out of 5

0218061001 0218061005 0218061010 0218061025 0218061080
IC0218061001EA 45.2 USD
IC0218061001 IC0218061005 IC0218061010 IC0218061025 IC0218061080
Neomycin sulfate ≥600 µg/mg USP
Neomycin sulphate

This product acts by binding to the 30S and 50S subunits, causing miscoding and inhibiting initiation and elongation during protein synthesis.


  • Binds to subunits
  • Blocks Ca2+ channels
  • Produced by Streptomyces
  • Loss on drying: <8.0%
  • pH: 5-7.5
  • Physical form: Poweder


Neomycin also blocks voltage-sensitive Ca2+ channels without affecting the Na+/Ca2+ antiporter in neurons.


Neomycin acts against both gram-positive and gram-negative bacteria.


Neomycin Trisulfate is produced by Streptomyces containing a minimum of 85% neomycin B. It has been used as a selection agent for prokaryotic cells transformed using the neo selectable marker gene, and to study ototoxic side effects of antibiotics, platelet-derived growth factor responses in certain fibroblasts, and extraction of Nuclear Phosphatidylinositol 4,5-Bisphosphate-Interacting Proteins.


It is recommended for use in cell culture applications at 50 mg/L.


Soluble in Water (50 mg/mL)

Formula: C₂₃H₄₆N₆O₁₃·3H₂SO₄
MW: 908.87 g/mol
Storage Temperature: Ambient
MDL Number: MFCD00150827
CAS Number: 1405-10-3
Merck Index: 12,06542

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR